59th Annual Meeting of the Japanese Society of Neurology

Sessions

Evening Seminar

7 results  (1 - 7)

  • Evening Seminar

[ES-01] Medtronic Japan Co., Ltd

The indication for Device aided therapy for sevear Parkinson's disease and follow-up led by Neurologists

Thu. May 24, 2018 7:05 PM - 8:05 PM Room 4 (Sapporo Geibunkan / Reimei (3F))

Chair: Hidemoto Saiki(Department of Neurology, Kitano Hospital, The Tazuke Kofukai Medical Research Institute)

  • Evening Seminar

[ES-02] Pfizer Japan Inc.

Diagnosis and treatment of peripheral nerve disease ~latest topic of FAP~

Thu. May 24, 2018 7:05 PM - 8:05 PM Room 5 (Sapporo Geibunkan / Seiryu (3F))

Chair: Yukio Ando(Department of Neurology Professor, Graduate School of Medical Sciences, Kumamoto University)

  • Evening Seminar

[ES-03] Takeda Pharmaceutical Company Limited

Treatment for Spinal-Bulbar Muscular Atrophy(SBMA)

Thu. May 24, 2018 7:05 PM - 8:05 PM Room 9 (Royton Sapporo / Regent Hall (2F))

Chair: Hidenao Sasaki(Professor, Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University)

  • Evening Seminar

[ES-04] Janssen Pharmaceutical K.K.

Prevention of dementia by lifestyle factors and early diagnosis using amyloid PET

Thu. May 24, 2018 7:05 PM - 8:05 PM Room 10 (Royton Sapporo / Highness Hall (2F))

Chair: Shun Shimohama(Department of Neurology, School of Medicine, Sapporo Medical University)

  • Evening Seminar

[ES-05] Novartis Pharma K.K

The position of L-dopa therapy in the new Parkinson's Disease clinical guideline

Fri. May 25, 2018 5:30 PM - 6:30 PM Room 8 (Royton Sapporo / Empress Hall (2F))

Chair: Miho Murata(National Center of Neurology and Psychiatry Director General)

  • Evening Seminar

[ES-06] Eli Lilly Japan K.K.

Paradigm Shift of Dementia Diagnosis - from Functional Imaging to Pathological Imaging -

Fri. May 25, 2018 5:30 PM - 6:30 PM Room 9 (Royton Sapporo / Regent Hall (2F))

Chair: Masahito Yamada(Professor, Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences)

  • Evening Seminar

[ES-07] Biogen Japan Ltd. / Eisai Co., Ltd.

PML risk management in the treatment of Multiple Sclerosis

Fri. May 25, 2018 5:30 PM - 6:30 PM Room 10 (Royton Sapporo / Highness Hall (2F))

Chair: Makoto Matsui(Department of Neurology, Kanazawa Medical University)